Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007

David J Farrell, David Felmingham, Jemma Shackcloth, Laura Williams, Kirsty Maher, Russell Hope, David M Livermore, Robert C George, Geraldine Brick, Siobhan Martin, Rosy Reynolds, BSAC Working Parties on Resistance Surveillance

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Pneumococcal disease is prevalent and is a cause of significant morbidity and mortality in the UK and Ireland. We describe the antimicrobial susceptibility and serotype distributions of Streptococcus pneumoniae causing bacteraemia and community-acquired pneumonia in these countries from 1999/2000 to 2006/7, predominantly prior to the introduction of the heptavalent pneumococcal conjugate vaccine (PCV7) into the standard vaccination schedule in September 2006.
Original languageEnglish
Pages (from-to)ii87-95
JournalJournal of Antimicrobial Chemotherapy
Volume62
Issue numberSuppl 2
DOIs
Publication statusPublished - Nov 2008

Keywords

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents
  • Bacteremia
  • Bacterial Typing Techniques
  • Child
  • Child, Preschool
  • Community-Acquired Infections
  • Drug Resistance, Bacterial
  • Female
  • Great Britain
  • Humans
  • Infant
  • Infant, Newborn
  • Ireland
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pneumococcal Infections
  • Respiratory Tract Infections
  • Sentinel Surveillance
  • Serotyping
  • Streptococcus pneumoniae

Cite this